Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
Clinical trial NCT00345826 · COMPLETED
Trial details
- NCT number
- NCT00345826
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2010-07-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.